The world's first bivalent mRNA vaccine candidate against respiratory syncytial virus, or RSV, kicked off Phase I clinical ...

The holidays are fast approaching along with cooler weather and various respiratory illnesses. Here's when to get your ...

As cold and flu season ramps up, the most vulnerable among us need extra protection. Infants are among the most susceptible ...